2 hours ago
2
Last year’s survey successful the diary Obesity had revealed that of radical prescribed weight-loss drugs, conscionable 44 per cent were inactive taking them aft 3 months and lone 19 per cent aft 1 year.
Recently, Danish drugmaker Novo Nordisk shared the archetypal quality astir CagriSema, the adjacent procreation of semaglutide, sold arsenic Ozempic for the attraction of diabetes, and Wegovy for obesity, arsenic a game-changer. It has been predicted to trim value nonaccomplishment by astir 25 per cent successful fractional the clip that Wegovy takes. But tin these caller drugs regenerate accepted treatments for diabetes connected a ample scale?
That’s the question that Dr KP Singh, erstwhile faculty, the Department of Endocrinology, PGI and presently the Director, Endocrinology, Fortis Hospital, Mohali, has raised, arguing wherefore we should not disregard accepted drugs and therapies. “GLP-1 receptor agonists similar semaglutide person revolutionised the attack to treating some diabetes and obesity. But support successful caput that astir patients are inactive managed by oral medications to dainty diabetes and not injections, astatine slightest successful the aboriginal stages,” helium explains.
Who should usage these drugs?
These drugs aren’t simply “weight nonaccomplishment shots”, done connected a whim. There are capable examples of however they person gone incorrect successful radical who simply wanted to sound disconnected the pounds and who were riddled with broadside effects similar gastro-intestinal problems. Last year’s survey successful the diary Obesity had revealed that of radical prescribed weight-loss drugs, conscionable 44 per cent were inactive taking them aft 3 months and lone 19 per cent aft 1 year. Another survey showed that those who stopped attraction with Mounjaro (another GLP-1 drug) regained astir 60 per cent of their mislaid weight. Just arsenic these drugs thrust you to suffer weight, their withdrawal tin propulsion you to instrumentality to aged habits faster than you think. Besides, tin you proceed connected these drugs lifelong?
Frankly, these are aesculapian interventions intended for patients with diabetes, obesity oregon weight-related wellness conditions and are particularly beneficial for patients with bosom disease. These medications are not due for cosmetic value nonaccomplishment oregon short-term use.
Is the value nonaccomplishment speech overplayed?
The drugs are precise effectual with objective trials of semaglutide showing mean value reductions of astir 15 per cent successful objective trials. However, we indispensable retrieve that obesity is simply a analyzable chronic illness requiring broad management. These medications enactment champion arsenic portion of a holistic attack including dietary modifications, carnal enactment and behavioural changes. The maximal payment of these drugs requires continuous semipermanent usage and grading the dose implicit clip to support oregon attain a circumstantial effect oregon to alteration the hazard of adverse effects.
Are accepted therapies for diabetes becoming irrelevant?
No. Conventional therapies inactive person a large relation to play successful diabetes absorption arsenic these injectable drugs should beryllium considered first-line therapy successful patients with bosom illness and those who necessitate an injectable medicine from the get-go. Despite GLP-1, galore patients volition necessitate aggregate medications to power their humor sugars and execute their goal.
Also, large women, patients with acute complications from diabetes, oregon patients who request to power their humor sweetener levels rapidly (e.g. starring up to large surgery) inactive necessitate accepted diabetes medications similar insulin. Patients with pancreatic disease, Type 1 diabetes, gallstones oregon those with tumours of the endocrine glands should not instrumentality GLP1 drugs.
How is CagriSema antithetic from Ozempic and Wegovy?
The progressive constituent of Ozempic and Wegovy is semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RAs). This mimics the gut hormone GLP-1, which promotes the accumulation of insulin, regulates humor sweetener levels, slows the emptying of the stomach, and affects the country of the encephalon that controls satiety. CagriSema, successful summation to mimicking GLP-1, mimics 2 different gut hormones. The archetypal is amylin, a hormone that is co-secreted with insulin successful the pancreas and regulates humor sweetener levels, slows digestion and enhances satiety. It besides mimics calcitonin, a hormone that regulates calcium levels successful the blood. Calcium plays a relation successful insulin secretion.
Looking up to CagriSema – it is presently nether probe and our centre is simply a large tract for cardinal objective trials investigating its usage successful galore objective conditions. The information from early-phase trials is promising, but we indispensable support technological rigour successful assessing each caller treatments. We volition request the results from the ongoing ample trials to measure the efficacy and semipermanent information illustration of CagriSema and hold for support from regulatory bodies.
These medications correspond important advances successful our therapeutic arsenal, but they’re not magic bullets. The aboriginal of metabolic wellness absorption lies successful personalised approaches that cautiously lucifer the close attraction to the close diligent astatine the close time, fare and exercise.
.png "indianexpress.")
.png "khaleejtimes")
.png "arabnews")
.png "gulfnews"){kind=logo}
English (US) · 
Hindi (IN) ·